Lv4
750 积分 2024-07-15 加入
Reduced Severity of Tissue Injury Within the Infarct May Partially Mediate the Benefit of Reperfusion in Ischemic Stroke
12小时前
已完结
Improvements in clinical and patient-reported outcomes and durability of response with the targeted oral peptide icotrokinra in adolescents with moderate-to-severe plaque psoriasis: One-year results from the ICONIC-LEAD randomized controlled trial
5天前
已关闭
Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials
7天前
已完结
Biologics for Psoriasis
14天前
已完结
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
18天前
已完结
A Multicenter National Study of AL Amyloidosis in China: Insights Into Real‐World Diagnosis, Treatment, and Prognosis
26天前
已完结
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review
1个月前
已完结
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab
1个月前
已完结
Effect of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors on Lipoprotein(a) Levels: An Umbrella Review of Meta-analyses of Randomized Controlled Trials
1个月前
已完结
Therapeutic Effects of PCSK9 Inhibitors on Lp(a)-Associated Atherosclerosis: Evidence and Perspectives
1个月前
已完结
皖公网安备34019202002308
